These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
175 related articles for article (PubMed ID: 20829819)
21. Natural Products and Derivatives Targeting at Cancer Energy Metabolism: A Potential Treatment Strategy. Wang QQ; Li MX; Li C; Gu XX; Zheng MZ; Chen LX; Li H Curr Med Sci; 2020 Apr; 40(2):205-217. PubMed ID: 32337682 [TBL] [Abstract][Full Text] [Related]
22. Dichloroacetate (DCA) as a potential metabolic-targeting therapy for cancer. Michelakis ED; Webster L; Mackey JR Br J Cancer; 2008 Oct; 99(7):989-94. PubMed ID: 18766181 [TBL] [Abstract][Full Text] [Related]
25. The role of phosphometabolites in cell proliferation, energy metabolism, and tumor therapy. Mazurek S; Boschek CB; Eigenbrodt E J Bioenerg Biomembr; 1997 Aug; 29(4):315-30. PubMed ID: 9387092 [TBL] [Abstract][Full Text] [Related]
26. Anticancer strategies based on the metabolic profile of tumor cells: therapeutic targeting of the Warburg effect. Chen XS; Li LY; Guan YD; Yang JM; Cheng Y Acta Pharmacol Sin; 2016 Aug; 37(8):1013-9. PubMed ID: 27374491 [TBL] [Abstract][Full Text] [Related]
27. Hypoxia, cancer metabolism and the therapeutic benefit of targeting lactate/H(+) symporters. Marchiq I; Pouysségur J J Mol Med (Berl); 2016 Feb; 94(2):155-71. PubMed ID: 26099350 [TBL] [Abstract][Full Text] [Related]
28. Targeting cancer energy metabolism: a potential systemic cure for cancer. Kim SY Arch Pharm Res; 2019 Feb; 42(2):140-149. PubMed ID: 30656605 [TBL] [Abstract][Full Text] [Related]
29. Oncology's "Hockey Stick" Moment for the Cost of Cancer Drugs-The Climate Is About to Change. Polite BN; Ratain MJ; Lichter AS JAMA Oncol; 2021 Jan; 7(1):25-26. PubMed ID: 33001134 [No Abstract] [Full Text] [Related]
30. Targeting respiratory complex I to prevent the Warburg effect. Vatrinet R; Iommarini L; Kurelac I; De Luise M; Gasparre G; Porcelli AM Int J Biochem Cell Biol; 2015 Jun; 63():41-5. PubMed ID: 25668477 [TBL] [Abstract][Full Text] [Related]
31. Multi-modality imaging to assess metabolic response to dichloroacetate treatment in tumor models. Neveu MA; De Preter G; Joudiou N; Bol A; Brender JR; Saito K; Kishimoto S; Grégoire V; Jordan BF; Krishna MC; Feron O; Gallez B Oncotarget; 2016 Dec; 7(49):81741-81749. PubMed ID: 28082726 [TBL] [Abstract][Full Text] [Related]
33. Acidosis-induced metabolic reprogramming in tumor cells enhances the anti-proliferative activity of the PDK inhibitor dichloroacetate. Schoonjans CA; Joudiou N; Brusa D; Corbet C; Feron O; Gallez B Cancer Lett; 2020 Feb; 470():18-28. PubMed ID: 31812695 [TBL] [Abstract][Full Text] [Related]
34. Drug discovery strategies in the field of tumor energy metabolism: Limitations by metabolic flexibility and metabolic resistance to chemotherapy. Amoedo ND; Obre E; Rossignol R Biochim Biophys Acta Bioenerg; 2017 Aug; 1858(8):674-685. PubMed ID: 28213330 [TBL] [Abstract][Full Text] [Related]
35. Drug pipeline: 1Q12. Mak C Nat Biotechnol; 2012 May; 30(5):383. PubMed ID: 22565954 [No Abstract] [Full Text] [Related]
36. mTORC1-Dependent Metabolic Reprogramming Underlies Escape from Glycolysis Addiction in Cancer Cells. Pusapati RV; Daemen A; Wilson C; Sandoval W; Gao M; Haley B; Baudy AR; Hatzivassiliou G; Evangelista M; Settleman J Cancer Cell; 2016 Apr; 29(4):548-562. PubMed ID: 27052953 [TBL] [Abstract][Full Text] [Related]
37. Emerging approaches to target tumor metabolism. Ross SJ; Critchlow SE Curr Opin Pharmacol; 2014 Aug; 17():22-9. PubMed ID: 25048629 [TBL] [Abstract][Full Text] [Related]
38. An update on therapeutic opportunities offered by cancer glycolytic metabolism. Granchi C; Fancelli D; Minutolo F Bioorg Med Chem Lett; 2014 Nov; 24(21):4915-25. PubMed ID: 25288186 [TBL] [Abstract][Full Text] [Related]
39. Growth industry. Lewis R Nature; 2004 Mar; 428(6980):348-9. PubMed ID: 15029202 [No Abstract] [Full Text] [Related]